{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T04:46:18Z","timestamp":1781412378441,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["CMFHR11135"],"award-info":[{"award-number":["CMFHR11135"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (HP) eradication therapy (HPE) is recommended for patients with unexplained immune thrombocytopenia (ITP); however, the role of HPE in preventing ITP in patients with HP infection remains unclear. Therefore, this study was designed to clarify it.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was conducted at a tertiary medical center and included all adult patients with HP infection between January 1, 2016 and December 31, 2018. We compared the risk of developing ITP between patients with and without HPE. All patients were followed up until December 31, 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After excluding patients with thrombocytopenia, 1995 adult patients with HP infection, including 1188 patients with HPE and 807 patients without HPE, were included in this study. The mean age of the patients with HPE was 57.9\u00a0years, whereas that of those without HPE was 61.6\u00a0years. The percentage of males was 56% in patients with HPE and 59% in those without HPE. Patients without HPE had a higher risk of ITP than those with HPE after adjusting for age, sex, the Charlson Comorbidity Index, and comorbidities [adjusted odds ratio (OR) 1.76; 95% confidence interval (CI) 1.16\u20132.68]. Stratified analyses showed that the higher risk was found only in males (adjusted OR: 1.70; 95% CI 1.03\u20132.80). In addition to HPE, male sex and anemia were independent predictors of ITP in patients with HP infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study showed that adult patients with HP infection not receiving HPE had a higher risk of developing ITP. We suggest that HPE should be considered, particularly in males and those who have anemia, to prevent ITP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-023-02664-z","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T11:05:33Z","timestamp":1675854333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan"],"prefix":"10.1186","volume":"23","author":[{"given":"Mitsuhiro","family":"Koseki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2011Jen","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"2664_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112:212\u201339.","journal-title":"Am J Gastroenterol"},{"key":"2664_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420\u20139.","journal-title":"Gastroenterology"},{"key":"2664_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381:945\u201355.","journal-title":"N Engl J Med"},{"key":"2664_CR4","doi-asserted-by":"publisher","unstructured":"Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. 2022;gutjnl-2022-327745. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745.","DOI":"10.1136\/gutjnl-2022-327745"},{"key":"2664_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00277-014-2268-9","volume":"94","author":"H Kim","year":"2015","unstructured":"Kim H, Lee WS, Lee KH, et al. Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. Ann Hematol. 2015;94:739\u201346.","journal-title":"Ann Hematol"},{"key":"2664_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1532\/IJH97.04146","volume":"81","author":"K Fujimura","year":"2005","unstructured":"Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162\u20138.","journal-title":"Int J Hematol"},{"key":"2664_CR7","unstructured":"Introduction for Chimei hospital. 2022. https:\/\/www.medicaltravel.org.tw\/MedicalTraining\/Hospital-Content.aspx?a=2635&l=1&fromCnt=1. Accessed 13 Sep 2022."},{"key":"2664_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12185-019-02790-z","volume":"111","author":"H Kashiwagi","year":"2020","unstructured":"Kashiwagi H, Kuwana M, Hato T, et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 revision. Int J Hematol. 2020;111:329\u201351.","journal-title":"Int J Hematol"},{"key":"2664_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5045\/br.2017.52.4.254","volume":"52","author":"JH Jang","year":"2017","unstructured":"Jang JH, Kim JY, Mun YC, et al. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res. 2017;52:254\u201363.","journal-title":"Blood Res"},{"key":"2664_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5045\/br.2022.2022043","volume":"57","author":"YH Park","year":"2022","unstructured":"Park YH, Kim DY, Kim S, et al. Management of immune thrombocytopenia: 2022 update of Korean experts recommendations. Blood Res. 2022;57:20\u20138.","journal-title":"Blood Res"},{"key":"2664_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/acem.14339","volume":"28","author":"YM Chen","year":"2021","unstructured":"Chen YM, Kao Y, Hsu CC, et al. Real-time interactive artificial intelligence of things-based prediction for adverse outcomes in adult patients with pneumonia in the emergency department. Acad Emerg Med. 2021;28:1277\u201385.","journal-title":"Acad Emerg Med"},{"key":"2664_CR12","doi-asserted-by":"publisher","first-page":"11221","DOI":"10.3748\/wjg.v21.i40.11221","volume":"21","author":"YK Wang","year":"2015","unstructured":"Wang YK, Kuo FC, Liu CJ, et al. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015;21:11221\u201335.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2664_CR13","doi-asserted-by":"publisher","first-page":"e12368","DOI":"10.1111\/hel.12368","volume":"22","author":"BS Sheu","year":"2017","unstructured":"Sheu BS, Wu MS, Chiu CT, et al. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter. 2017;22(3):e12368.","journal-title":"Helicobacter"},{"key":"2664_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1631\/jzus.B1300109","volume":"15","author":"YQ Huang","year":"2014","unstructured":"Huang YQ, Gou R, Diao YS, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15:58\u201366.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2664_CR15","doi-asserted-by":"crossref","unstructured":"Diagnostic approach to the adult with unexplained thrombocytopenia. UpToDate, 2022. https:\/\/www.uptodate.com\/contents\/diagnostic-approach-to-the-adult-with-unexplained-thrombocytopenia\/print. Accessed 13 Sep 2022.","DOI":"10.1097\/01.NPR.0000884876.70098.dd"},{"key":"2664_CR16","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1371\/journal.pmed.0030362","volume":"3","author":"J Zimmer","year":"2006","unstructured":"Zimmer J, Hentges F, Andres E. Borderline thrombocytopenia or mild idiopathic thrombocytopenic purpura? PLoS Med. 2006;3:e362.","journal-title":"PLoS Med"},{"key":"2664_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","volume":"124","author":"T Takahashi","year":"2004","unstructured":"Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124:91\u20136.","journal-title":"Br J Haematol"},{"key":"2664_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12185-008-0247-4","volume":"89","author":"Y Bai","year":"2009","unstructured":"Bai Y, Wang Z, Bai X, et al. Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol. 2009;89:142\u20139.","journal-title":"Int J Hematol"},{"issue":"16","key":"2664_CR19","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.3390\/jcm11164822","volume":"11","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Okamoto A. Helicobacter pylori Infection and chronic immune thrombocytopenia. J Clin Med. 2022;11(16):4822.","journal-title":"J Clin Med"},{"key":"2664_CR20","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1016\/j.lpm.2012.02.010","volume":"41","author":"E Andres","year":"2012","unstructured":"Andres E, Mecili M, Fothergill H, Zimmer J, Vogel T, Maloisel F. Gender-related analysis of the clinical presentation, treatment response and outcome in patients with immune thrombocytopenia. Presse Med. 2012;41:e426\u201331.","journal-title":"Presse Med"},{"key":"2664_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.17140\/WHOJ-2-e004","volume":"2","author":"E Andres","year":"2016","unstructured":"Andres E. What impact for sex difference on immune thrombocytopenic purpura? Women Health Open J. 2016;2:e1\u20133.","journal-title":"Women Health Open J"},{"key":"2664_CR22","first-page":"547","volume":"17","author":"S Afsharipour","year":"2014","unstructured":"Afsharipour S, Nazari R, Douraghi M. Seroprevalence of anti-Helicobacter pylori and anti-cytotoxin-associated gene A antibodies among healthy individuals in center of Iran. Iran J Basic Med Sci. 2014;17:547\u201352.","journal-title":"Iran J Basic Med Sci"},{"key":"2664_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1083-4389.2004.00261.x","volume":"9","author":"T Ando","year":"2004","unstructured":"Ando T, Tsuzuki T, Mizuno T, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter. 2004;9:443\u201352.","journal-title":"Helicobacter"},{"issue":"5","key":"2664_CR24","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/hel.12914","volume":"27","author":"MJ Chen","year":"2022","unstructured":"Chen MJ, Bair MJ, Chen PY, et al. Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: an updated cross-sectional survey and meta-analysis. Helicobacter. 2022;27(5):e12914.","journal-title":"Helicobacter"},{"key":"2664_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3109\/09537104.2013.841883","volume":"25","author":"N Teawtrakul","year":"2014","unstructured":"Teawtrakul N, Sawadpanich K, Sirijerachai C, Chansung K, Wanitpongpun C. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura. Platelets. 2014;25:548\u201351.","journal-title":"Platelets"},{"key":"2664_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.713908","volume":"8","author":"Q Huang","year":"2021","unstructured":"Huang Q, Jia X, Chu Y, Zhang X, Ye H. Helicobacter pylori Infection in geriatric patients: current situation and treatment regimens. Front Med (Lausanne). 2021;8: 713908.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02664-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T11:05:55Z","timestamp":1675854355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2664"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02664-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2196609\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"23 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted strictly according to the Declaration of Helsinki and approved by the IRB of the CMMC (IRB serial no. 11103-002). All patients\u2019 data were anonymized. Patient informed consent was waived because of the retrospective and observational nature of the study. The welfare of the patients was unaffected by the waiver.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}